Omalizumab Provides Long-term Control in Patients with Moderate-to-severe Allergic Asthma

@inproceedings{Bollinger2003OmalizumabPL,
  title={Omalizumab Provides Long-term Control in Patients with Moderate-to-severe Allergic Asthma},
  author={Mary Beth Bollinger and Elizabeth C. Matsui and Robert A. Wood},
  year={2003}
}
Buhl R, Soler M, Matz J, et al. Eur Respir J. 2002;20:73–78 Purpose of the Study. To examine the ability of omalizumab, an anti-immunoglobulin E (anti-IgE) agent, to maintain long-term disease control in patients with moderate-to-severe allergic asthma. Study Population. Four hundred eighty-three patients with moderate-to-severe allergic asthma maintained on beclomethasone diproprionate. Methods. Four hundred eighty-three patients with physician-diagnosed moderate-to-severe allergic asthma were… CONTINUE READING
49 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

Similar Papers

Loading similar papers…